Health Secretary Matt Hancock said that a small-scale antibody surveillance study has shown that about 17% of people in London and 5% in the rest of the country have had COVID-19.
Hancock said the study came out of Britain’s government-funded effort to develop antibody tests. He announced that Britain had signed contracts with pharmaceutical company Roche and Abbott to supply more than 10 million antibody tests. He said they would begin rolling out the tests in phases beginning next week, starting with health workers.
Hancock also reported a 14% decrease in COVID-19 patients being treated in hospitals since last week. He said that over 3 million people had been tested for the virus, of which 250,908 tested positive. The COVID-19 death toll in Britain stands at 36,042.